Fierce Pharma March 28, 2024
Andrea Park

Less than a year after divvying up its marketing work between two firms, Publicis Groupe and Interpublic Group, Pfizer is tweaking the distribution of duties among the pair.

The Big Pharma has shifted its global creative business to Publicis’ purview, it confirmed to Fierce Pharma Marketing.

Previously, IPG was Pfizer’s lead creative partner; it’ll reportedly hang on to product PR and health brief responsibilities for the drugmaker, according to Campaign. Publicis, meanwhile, adds creative to an existing list of Pfizer marketing duties that includes data, media and production.

“As Pfizer evolves its marketing model, the company is deeply committed to the flexible, two-agency partnership that was put in place last year,” Pfizer said in a statement sent to Fierce Pharma...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
11 drugs now in shortage
AbbVie tries to reassure investors on Humira biosimilar threat
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
This Biotech Startup Aims To Speed Up Drug Testing On Animals
Scientists reveal new method that could reduce waste from drug manufacturing

Share This Article